orforglipron vs oral semaglutide obesity #diabetes #endocrinology #glp1 #obesitytreatment #clinicaltrials #ada #easd #eco #endo2025 #seen #seedo #sed Comparison of Oral Semaglutide (Wegovy)

While it is marketed as an effective non-invasive fat reduction method, there are concerns about its safety and a lack of clinical evidence supporting its efficacy, especially when compared to more established alternatives like ultrasound-based treatments such as ULTRAcel Q+

Bonilla, E., Medina-Leendertz, S., Mora, M., Vielma, J

Side Effects of GHK-Cu | Verdict With over four decades of research to back its benefits, GHK-Cu has also demonstrated a positive safety profile

On the other hand, its high prevalence in older populations and frequent coexistence with age-related changes in body composition, including sarcopenia, visceral adiposity, and metabolic inflexibility, suggest that MACS may also act as an amplifying or precipitating factor within the broader pathophysiological spectrum of SAGE-DM